Chemical Structure (Tryvio 01)
Tryvio Tablet, Film Coated
Product Images NDC 80491-8012
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tryvio (NDC 80491-8012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Idorsia Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chart (Tryvio 02)
This text appears to be listing acceptable birth control options, including methods such as the copper IUD, hormonal implants, male condoms, vaginal rings, and oral contraceptives. The options are presented in a clear format with details of each method provided.*
Principal Display Panel (30 Tablet Bottle Carton)
This is the information for a medication called "TRYVIO" containing 12.5mg of aprocitentan in tablet form. The recommended dosage instructions are not provided in the text, but it suggests referring to the prescribing information for guidance. The tablets should be stored at a temperature between 20 to 25°C in a child-resistant package and kept out of reach of children. The medication is distributed by Dorsa Pharmaceuticals in the US and is for prescription use only. Each package contains 30 coated tablets. The text also includes a lot number for tracking purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
